Analysis |

Can Israel Actually Meet Netanyahu's Ambitious COVID-19 Vaccine Target?

Meirav Arlosoroff
Meirav Arlosoroff
Send in e-mailSend in e-mail
Send in e-mailSend in e-mail
Meirav Arlosoroff
Meirav Arlosoroff

If the reports are correct, Israel is in debt to its prime minister, Benjamin Netanyahu. Pfizer and its partner BioNTech are said to be ready to supply the country with up to four million doses, enough for two million people by the end of December. The first shipment arrived on Wednesday.

Arranging to have the vaccine delivered so quickly, if it indeed happens, has to be seen by everyone as a personal success for Netanyahu. It’s not clear whether he was able to do that by exerting pressure on Pfizer through the White House or appealed directly to Pfizer’s CEO, but either way, he did it.

Click the alert icon to follow topics:

Comments